Differences in structural and pain phenotypes between monoiodoacetae and meniscal transection models of osteoarthritis  by Mapp, P.I. et al.
ĂAbstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S61bone marrow acquired properties of anti-angiogenesis to achieve good
restorative effects of articular cartilage (Tissue Eng Part A 2008;14:1225-
1235.). Then we reported that intravenous administration of bevacizumab,
a humanized monoclonal anti-VEGF antibody contributes to the repair of
articular cartilage in an osteochondral defect model (Arthritis research and
therapy 2010,12:R178.). The object of this study was to investigatewhether
cartilage degeneration is prevented following intravenous administration
of bevacizumab in the rabbit model of anterior cruciate ligament tran-
section (ACLT).
Methods: ACLT rabbits were classiﬁed into two groups: Group B, admin-
istration of bevacizumab (n¼15; 100 mg intravenous injection on the day
of 1 and 3 weeks after surgery); and the Control (n¼16).
Osteophyte formation was evaluated macroscopically and OA repair sites
were also evaluated using OARSI modiﬁed Mankin score.
Results: One month after ACLT, macroscopic evaluation of both groups
showed some parts of joints included osteophyte formation and almost
smooth joints surface of the articular cartilage (Figure.1). However histo-
logic assessment demonstrated that articular cartilage was recognized loss
of staining in Control. Group B was tended to retain staining (Figure.2).
3 months after ACLT, macroscopic evaluation of the Control showed
marked progression of arthritis and osteophyte formation. Group B still
showed smooth joint surfaces in the most regions of the articular cartilage
and osteophyte formation was restrained (Figure.3, 4).Ă
ĂOARSI histological score was used to evaluate the quality of the repair
tissue (Figure.5). Osteophyte formation score 3 month after ACLT in B
group was signiﬁcantly lower than control (Figure.6).
Conclusions: The early intervention of intravenous administration of
bevacizumabwould be useful to prevent the post-traumatic osteoarthritis.
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DIFFERENCES IN STRUCTURAL AND PAIN PHENOTYPES BETWEEN
MONOIODOACETAE AND MENISCAL TRANSECTION MODELS OF
OSTEOARTHRITIS
P.I. Mapp 1, D.R. Sagar 1,2, S. Ashraf 1, S. Suri 1, V. Chapman 1,2,
D.A. Walsh 1. Arthritis Research UK Pain Centre, University of Nottingham,
UK. 1Univ. of Nottingham, Nottingham, UNITED KINGDOM; 2 Sch. of BioMed.
Sci., University of Nottingham, United Kingdom
Purpose: To compare pathology in two animal models of osteoarthritis at
several time points after the induction of arthritis and to investigate pain
behaviour over the course of the experiment.
Methods:Meniscal transection (MNX) arthritis was induced by transection
of the meniscus in 180g male Sprague Dawley rats. Controls were animals
subjected to sham surgery in which the collateral ligament was removed
but the meniscus was left intact. Monosodium iodoacetate(MIA) arthritis
was induced by the intra-articular injection of 1mg of sodium mono-
iodacetate dissolved in 50ml sterile saline. Separate groups of animals
injected with saline were controls. Groups of animals (n¼8) were sacri-
ﬁced at 14, 35 and 45 days. Pain behaviour was monitored by differential
weight bearing (g) and paw withdrawal thresholds (g). Pathology was
scored for synovial inﬂammation (0-3), chondropathy (0-15), osteophytes
(0-3) and the number of osteochondral channels /mm length of cartilage
were counted. Data are means (95% CI).
Results: Inﬂammation in the synovium remained constant over time. At
day 49, MNX- treated knees had greater inﬂammation 1.7 (1.2-2.1) than
Sham controls 0.2 (0.02-0.4) p<0.01, and MIA- treated knees were more
inﬂamed 0.6 (0.2-0.8) than saline-injected controls 0.0 (0-0). MNX- treated
knees were more inﬂamed than MIA -treated knees, p> 0.01. Osteophyte
scores were greater at all time points in MNX- treated knees when
compared to MIA -treated knees. At day 49 osteophytes scores were
greater in MNX- treated knees 2.8 (2.6-3.0) than sham 0.23 (0.02-0.4),
p<0.01, and greater in MIA-treated knees 1.0 (0.5-1.4) than in saline-
injected controls 0 (0-0), p<0.01. Osteophyte scores were greater in MNX-
treated knees than in MIA-treated knees (p<0.01). Chondropathy scores
increased in both treatment groups with time and did not differ between
MNX-treated knees and MIA-treated knees. At day 49 MNX-treated knees
had higher osteophyte scores 12.7 (11.1-14.3) than sham controls 2.8 (0.8-
4.8), p<0.01. Osteophyte scores in MIA-treated knees 9.7 (7.5-11.8) were
higher than in saline controls 0 (0-0), p<0.01. At day 49 MNX-treated
animals displayed greater numbers of channels crossing the osteochondral
junction 0.25 (0.1-0.4) channels/mm compared to sham controls 0.01
(0.03-0.1), MIA-treated knees 0.1 (0.09-0.1) and saline controls 0.04 (0.01-
0.2). MNX- treated animals displayed greater weight bearing asymmetry
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greater hindpaw allodynia than did MNX-treated animals.
Conclusions:We have compared two commonly induced models of OA in
rats, within a single experiment using identical assessment tools. Although
both models display features of OA, including chondropathy, osteopytosis,
synovitis and pain behaviour, differences between the models may indi-
cate that they each uniquely reﬂect different aspects of human OA. In
particular, the MNX model is characterised by greater synovitis and
osteophyte formation, and persistence of osteochondral channels, whereas
the MIA model is associated with more pronounced distal allodynia.
Appropriate selection of OA models depends on relevance to the research
hypothesis, and to OA phenotype which it is intended to model.
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DEVELOPMENT AND VALIDATION OF MECHANICAL ALLODYNIA AS
A PAIN READOUT IN A PRECLINICAL MODEL OF OSTEOARTHRITIS
R.V. Kamath 1, G. Simler 1, C. Zhou 2, M. Hart 1, S. Joshi 2, P. Honore 1. 1Abbott
Labs, Worcester, MA; 2Abbott Labs, Chicago, IL, USA
Purpose: Osteoarthritis (OA) is an age-related joint disease characterized
by progressive degeneration of articular cartilage and development of
chronic pain. Although a number of experimental models of OA have been
employed to investigate the underlying etiologies of cartilage degenera-
tion, there have been relatively few reports of the characterization of the
chronic pain associated with animal models of OA. Moreover, the appli-
cation of these models in the assessment of the analgesic efﬁcacy of
putative therapeutics remains largely unexplored. The purpose of the
present study was to develop and validate mechanical allodynia as a pain
readout with benchmark analgesics in the well-described and widely-used
destabilization of medial meniscus (DMM) model of OA.
Methods: Male sv129 mice were anesthetized and medial meniscotibial
ligament which anchors the medial meniscus to the tibial plateau was trans-
ected to induce OA. To determine optimal time-point for pain measurement,
decrease in paw withdrawal threshold (PWT) [mechanical allodynia (pain)]
was measured using von Frey ﬁlaments applied to the plantar surface of the
hind paw once every week after surgery for 5 weeks. To evaluate analgesics
efﬁcacy, on day 28 after surgery animals treated with either duloxetine; cel-
ecoxib or diclofenac were tested for PWT 60 minutes following oral adminis-
trationof thedrugwhile animals treatedwithgabapentinwere tested for PWT
180 minutes following oral administration of the drug.
Results: We have demonstrated that mice with DMM surgery were allo-
dynic as early as day 7 after surgery and exhibited a decrease in PWT
lasting through day 35. It was also observed that PWT in the sham group
was low indicating surgical pain during the early days following surgery
but PWT in sham animals recovered by Day 28 to normal values. Gaba-
pentin and duloxetine fully reversed established pain in a dose-related
manner while celecoxib and diclofenac partially reversed established pain
in a dose-related manner reaching a maximum inhibition of 62% and 64%
respectively at 30 mg/kg.
Conclusions: OA pain is a complex process involving both peripheral and
central sensitization. Development of analgesics drugs for OA has been
difﬁcult partly due to the lack of appropriate animal models to evaluate
pain in OA. We have reproduced and employed the mouse model of OA for
pain to evaluate the analgesic properties of benchmark analgesics. These
results suggest that this model could provide a tool to understand
molecular pathways involved in induction and maintenance of chronic
osteoarthritic pain and would also be useful in developing and evaluating
drugs for relieving OA pain.
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BLOCKADE OF BOTH IL-1A AND IL-1B BY A COMBINATION OF
MONOCLONAL ANTIBODIES PREVENTS THE DEVELOPMENT AND
REVERSES ESTABLISHED PAIN IN A PRECLINICAL MODEL OF
OSTEOARTHRITIS
R.V. Kamath 1, G. Simler 1, C. Zhou 2, M. Hart 1, S. Joshi 2, T. Ghayur 1,
P. Honore 1. 1Abbott Labs, Worcester, MA; 2Abbott Labs, Abbott Park, IL, USA
Purpose: Osteoarthritis (OA) is a disease of the whole joint with the
signature pathologic feature being articular cartilage loss leading to jointdestruction. The clinical symptoms of OA are pain and functional impair-
ment that includes joint stiffness and dysfunction. Interleukin-1 (IL-1)
plays a major role in the development and progression of osteoarthritis
(OA) both in terms of disease (structure) and symptoms (pain). IL-1a and
IL-1b are two distinct cytokines that bind to the same receptor and are
expressed in synovial membranes, cartilage, and synovial ﬂuid of patients
with OA. The purpose of the studies were to investigate the effects of
blockade of both IL-1a and IL-1b by a combination of anti-IL-1a and anti-
IL-1b monoclonal antibodies (mAbs) on a) the development of pain upon
chronic dosing and b) established pain upon acute dosing in the DMM
model of OA
Methods: Male sv129 mice were anesthetized and then medial menisco-
tibial ligament which anchors the medial meniscus to the tibial plateau
was transected to induce OA. Intraperitoneal (ip) treatments with IL-1
neutralizing antibodies (mouse anti-mouse IL-1amAb, mouse anti-mouse
IL-1b mAb alone, or in combination) was initiated the day of the surgery
and continued twice a week for 28 days (chronic dosing study) or started
on day 27 after surgery and pain evaluated on day 28, 24 hours post-
antibody dosing (acute dosing study). Pain was measured by decrease in
pawwithdrawal threshold of the injured hind limb (mechanical allodynia).
Knees were harvested and histopathologic alterations were scored and
characterized.
Results: Upon chronic dosing in the DMM model of OA, mechanical allo-
dynia (pain) in animals treated with either anti-IL-1a (6 mg/kg) or IL-1b
mAbs (6 mg/kg) was similar to mechanical allodynia observed in the
vehicle control group. However, combination therapy with both antibodies
at 6 mg/kg each signiﬁcantly reduced mechanical allodynia. In this study,
blockade of IL-1a and IL-1b also prevented cartilage degradation while
blocking either IL-1a or IL-1b had no effect. Upon acute dosing, combi-
nation therapy with both antibodies at 6 mg/kg each signiﬁcantly reversed
established mechanical allodynia observed 4 weeks post-surgery.
Conclusions: Our preclinical data demonstrate that combination of mouse
anti-mouse-IL-1a and anti-mouse-IL-1b mAb had signiﬁcant beneﬁcial
effects on histopathological parameters of mouse OA and prevented
development of pain as well as reversed established pain associated with
OA.We have recently reported on a novel dual-speciﬁc biologics approach,
termed Dual-Variable Domain-ImmunoglobulinTM (DVD-IgTM) that can
convert two pre-existing mAbs into a dual targeting agent by combining
the variable domains of two mAbs via naturally occurring linkers. These
preclinical proof of concept studies form the basis for further investigation
of therapeutic IL-1a/b DVD-IgTM molecules in human OA patients.
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ARTICULAR CARTILAGE DEGRADATION INDUCED BY EXTENSIVE
TREADMILL EXERCISE IS GREATLY EXACERBATED BY ESTROGEN
DEPLETION IN MICE.
K. Miyatake, K. Tsuji, J. Yamada, K. Abula, Y. Matsukura, I. Sekiya,
T. Muneta. Tokyo Med. and Dental Univ., Tokyo, Japan
Purpose: Osteoarthritis (OA) is considered to be a multifactorial disease
with factors such as chronic inﬂammation, aging, menopause, obesity, and
joint instability. For example, more than 39% of the patients develop OA in
the knee joint after anterior cruciate ligament reconstruction within 8
years. Too much mechanical stress by treadmill exercise induces severe
articular cartilage degradation in rats. Estrogen depletion by ovariectomy
(OVX) accelerates cartilage degradation in mice. These data clearly show
that each factor is involved in the pathogenesis of OA, however, orches-
trated effects of all these factors are still unclear. To analyze the crosstalk
between estrogen signal and mechanotransduction in articular cartilage
homeostasis, we examined articular cartilage damage after treadmill
exercise in OVX mice. Here we report that degree of articular cartilage
degradation induced by extensive treadmill exercise is greatly exacerbated
by estrogen depletion.
Methods: Twenty-four Balb/c mice (8 wks) were randomly divided into 4
groups, OVX+CAGE, OVX+RUN, SHAM+CAGE and SHAM+RUN. Two weeks
after ovariectomy or sham operation, RUN group was subjected to a forced
running for 6 weeks (5 days a week) at 20m/min for 100 minutes by
treadmill while CAGE group were left in cage ad libitum. Integrity of
articular cartilage was assessed by Hematoxylin and Eosin staining and
type II collagen immunostaining of sagittal sections. To assess articular
